Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease. (Record no. 5182)

MARC details
000 -LEADER
fixed length control field 03739nam a22003497a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200709s20202020 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0028-4793
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1056/NEJMoa1916370 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 32227753
245 ## - TITLE STATEMENT
Title Health-Status Outcomes with Invasive or Conservative Care in Coronary Disease.
251 ## - Source
Source New England Journal of Medicine. 2020 Mar 30
252 ## - Abbreviated Source
Abbreviated source N Engl J Med. 2020 Mar 30
253 ## - Journal Name
Journal name The New England journal of medicine
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2020
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2020
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
266 ## - Date added to catalog
Date added to catalog 2020-07-09
501 ## - WITH NOTE
Local holdings Available online from MWHC library: 1993 - present, Available in print through MWHC library: 1980 - present
520 ## - SUMMARY, ETC.
Abstract BACKGROUND: In the ISCHEMIA trial, an invasive strategy with angiographic assessment and revascularization did not reduce clinical events among patients with stable ischemic heart disease and moderate or severe ischemia. A secondary objective of the trial was to assess angina-related health status among these patients.
520 ## - SUMMARY, ETC.
Abstract CONCLUSIONS: In the overall trial population with moderate or severe ischemia, which included 35% of participants without angina at baseline, patients randomly assigned to the invasive strategy had greater improvement in angina-related health status than those assigned to the conservative strategy. The modest mean differences favoring the invasive strategy in the overall group reflected minimal differences among asymptomatic patients and larger differences among patients who had had angina at baseline. (Funded by the National Heart, Lung, and Blood Institute and others; ISCHEMIA ClinicalTrials.gov number, NCT01471522.). Copyright (c) 2020 Massachusetts Medical Society.
520 ## - SUMMARY, ETC.
Abstract METHODS: We assessed angina-related symptoms, function, and quality of life with the Seattle Angina Questionnaire (SAQ) at randomization, at months 1.5, 3, and 6, and every 6 months thereafter in participants who had been randomly assigned to an invasive treatment strategy (2295 participants) or a conservative strategy (2322). Mixed-effects cumulative probability models within a Bayesian framework were used to estimate differences between the treatment groups. The primary outcome of this health-status analysis was the SAQ summary score (scores range from 0 to 100, with higher scores indicating better health status). All analyses were performed in the overall population and according to baseline angina frequency.
520 ## - SUMMARY, ETC.
Abstract RESULTS: At baseline, 35% of patients reported having no angina in the previous month. SAQ summary scores increased in both treatment groups, with increases at 3, 12, and 36 months that were 4.1 points (95% credible interval, 3.2 to 5.0), 4.2 points (95% credible interval, 3.3 to 5.1), and 2.9 points (95% credible interval, 2.2 to 3.7) higher with the invasive strategy than with the conservative strategy. Differences were larger among participants who had more frequent angina at baseline (8.5 vs. 0.1 points at 3 months and 5.3 vs. 1.2 points at 36 months among participants with daily or weekly angina as compared with no angina).
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element IN PROCESS -- NOT YET INDEXED
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Weintraub, William S
790 ## - Authors
All authors Alexander KP, Baloch K, Bangalore S, Boden WE, Cohen DJ, Diaz A, Gosselin G, Harrell FE Jr, Hochman JS, ISCHEMIA Research Group, Jones PG, Mark DB, Maron DJ, Mavromatis K, Mavromichalis S, Newman JD, O'Brien SM, Reynolds HR, Rosenberg Y, Spertus JA, Stone GW, Weintraub WS
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1056/NEJMoa1916370">https://dx.doi.org/10.1056/NEJMoa1916370</a>
Public note https://dx.doi.org/10.1056/NEJMoa1916370
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 07/09/2020   32227753 32227753 07/09/2020 07/09/2020 Journal Article

Powered by Koha